Prevalence and associated risk factors of carotid plaque and artery stenosis in China: a population-based study

Qingjia Zeng, Chongyang Zhang, Xinyao Liu, Shengmin Yang, Muyuan Ma, Jia Tang, Tianlu Yin, Shanshan Zhao, Wenjun Tu, Hongpu Hu

Front. Med. ›› 2025, Vol. 19 ›› Issue (1) : 64-78.

PDF(1276 KB)
Front. Med. All Journals
PDF(1276 KB)
Front. Med. ›› 2025, Vol. 19 ›› Issue (1) : 64-78. DOI: 10.1007/s11684-024-1088-0
RESEARCH ARTICLE

Prevalence and associated risk factors of carotid plaque and artery stenosis in China: a population-based study

Author information +
History +

Abstract

Stroke is a critical health issue in China, and carotid artery stenosis and plaque play key roles in its prevalence. Despite the acknowledged significance of this condition, detailed information regarding the prevalence of carotid artery stenosis and plaque across the Chinese population has been scarce. This study analyzed data from the China Stroke High-risk Population Screening and Intervention Program for 2020–2021, focusing on 194 878 Chinese adults aged 40 years and above. It assessed the prevalence of carotid artery stenosis and plaque and identified their associated risk factors. Results revealed a standardized prevalence of 0.40% for carotid artery stenosis and 36.27% for carotid plaque. Notably, the highest rates of stenosis were observed in north and south China at 0.61%, while southwestern China exhibited the highest plaque prevalence at 43.17%. Key risk factors included older age, male gender, hypertension, diabetes, stroke, smoking, and atrial fibrillation. This study highlights significant geographical and demographic disparities in the prevalence of these conditions, underlining the urgent need for targeted interventions and policy reforms. These measures are essential for reducing the incidence of stroke and improving patient outcomes, addressing this significant health challenge in China.

Keywords

carotid plaque / carotid artery stenosis / prevalence / risk factors / Bigdata Observatory Platform for stroke in China

Cite this article

Download citation ▾
Qingjia Zeng, Chongyang Zhang, Xinyao Liu, Shengmin Yang, Muyuan Ma, Jia Tang, Tianlu Yin, Shanshan Zhao, Wenjun Tu, Hongpu Hu. Prevalence and associated risk factors of carotid plaque and artery stenosis in China: a population-based study. Front. Med., 2025, 19(1): 64‒78 https://doi.org/10.1007/s11684-024-1088-0

1 Introduction

Stroke is a prevalent public health concern on a global scale, ranking as the second leading cause of death and the third leading cause of combined death and disability worldwide [13]. In recent years, stroke has emerged as the primary cause of mortality in China [4,5]. According to a study conducted in 2022, the standardized prevalence of stroke among individuals aged 40 years and above in China has exhibited a gradual increase from 2.28% in 2013 to 2.64% in 2021, posing a significant health burden [6].
Carotid artery stenosis, which can be caused by the accumulation of carotid plaque, is a significant contributing factor to the occurrence of stroke [7]. Early intervention for individuals with carotid stenosis and plaque can effectively reduce the risk of stroke [8]. However, only a few studies have examined the prevalence of carotid plaque and artery stenosis in China, focusing on specific regions or populations [9,10]. These studies have yielded inconsistent results, underscoring the need for more comprehensive research to determine the prevalence of these conditions across the country. Numerous studies have consistently demonstrated that certain groups, including men, the elderly, those with lower income, smokers, and individuals with hypertension, dyslipidemia, and diabetes, among others, face an elevated risk of developing carotid plaque and artery stenosis [1114]. Many of these risk factors can be controlled through healthy lifestyle behavior. However, previous studies have not systematically evaluated risk factors for carotid plaque and artery stenosis, and this lack of information imposes a hurdle to the development of effective primary prevention strategies and the provision of updated information to stakeholders.
To fill this knowledge deficit, we employ cross-sectional data from the 2020–2021 China Stroke High-risk Population Screening and Intervention Program (CSHPSIP). Our objective is to determine the prevalence of carotid artery stenosis and plaque across China, identify associated risk factors, and conduct a detailed analysis of the burden brought by these conditions in various subpopulations and geographic regions. This research will elucidate the extent of these conditions in China, informing stakeholders, policymakers, and healthcare practitioners.

2 Materials and methods

The methodology employed in this study adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline [15]. The data used in this cross-sectional analysis were obtained from the Bigdata Observatory Platform for Stroke of China (BOSC), which is part of CSHPSIP, established by the China Stroke Prevention Project Committee (CSPPC) [16].

2.1 Study design and study participants

A nationwide cross-sectional study was executed from December 2020 to December 2021, involving hospital staff who conducted face-to-face interviews, physical examinations, and venous blood sample collection. This study is part of an ongoing population-based stroke prevention and control project that annual enrolls community-dwelling adults aged 40 years and above across 31 provinces in Chinese mainland. Participants were stratified into high-, medium-, and low-risk groups in accordance with the National Stroke Association’s stroke risk scorecard criteria. Participants in the high-risk category underwent neck vascular ultrasound to detect carotid intimal thickening, plaque, stenosis, or occlusion. Moreover, high-risk individuals, along with those diagnosed with carotid stenosis or with a history of stroke or transient ischemic attack, were further subjected to comprehensive laboratory tests, lifestyle interventions, and early clinical management.
Eligibility for inclusion in this study was based on the following criteria: (1) community residents aged 40 years or older who had resided in their current location for a minimum of 6 months, (2) completion of the ultrasound examination of neck vessels to identify abnormalities, and (3) provision of informed consent.

2.2 Procedure

The study protocol was created by the General Office of CSPPC under the National Health Commission of the People’s Republic of China. Hospital staff conducted face-to-face interviews and physical examinations and collected venous blood samples. A comprehensive questionnaire was utilized to collect data on demographic characteristics, laboratory test results, lifestyle-related risk factors, and individual and family medical histories.
The study adopted a stratified two-stage cluster sampling design to ensure a representative sample of Chinese mainland’s national population. Initially, cities were classified into developed, developing, and undeveloped categories on that basis of criteria, such as per capita gross domestic product (GDP), commercial resource concentration, commercial hub status, resident vitality, lifestyle diversity, and potential for future growth. The second stage involved listing all communities or villages within the chosen primary sampling units (PSUs), each with at least 2000 residents aged 40 years or older. One community or village was then randomly selected from this list. All eligible residents of these communities or villages, aged 40 years and above, who had been residing in the area for at least 6 months and had provided informed consent, were invited to participate. Participants engaged in in-person interviews and health checks at the project hospital. Communities or villages with a response rate below 85% were not included in the study.
Screening sites with a workload of less than 400 and a sex ratio that exceeded 1.4 or less than 0.5 were excluded. Subsequently, after adjusting for losses due to follow-up, deaths, and data abnormalities, this study encompassed 524 741 adults aged 40 years and above. From this cohort, 194 878 individuals, who underwent ultrasound examinations of neck vessels, were selected for the final analysis, as illustrated in Fig.1.
Fig.1 Study flowchart.

Full size|PPT slide

2.3 Diagnostic criteria

Carotid plaque was determined as the presence of one or more plaques in the carotid artery; carotid stenosis was characterized by a narrowing rate of 50% or more stenosis, including occlusion in any one of the neck arteries [17].
The definitions of the covariates were used to define and identify each risk factor. Obesity was determined based on a body mass index (BMI) of ≥28 kg/m2, following Chinese adult guidelines. Hypertension was defined as having a systolic blood pressure of ≥140 mmHg or a diastolic blood pressure of ≥90 mmHg. Diabetes mellitus was diagnosed if the fasting plasma glucose level was ≥7.0 mmol/L. Hyperlipidemia was identified by abnormal fasting plasma markers, such as total cholesterol levels of ≥6.22 mmol/L, triglycerides levels of ≥2.26 mmol/L, and high-density lipoprotein cholesterol levels of < 1.04 mmol/L. Stroke was diagnosed based on a certification or imaging certificate, i.e., computed tomography (CT)/magnetic resonance imaging (MRI), from a secondary or higher-level medical facility, specifically Level II and above hospitals. Atrial fibrillation was defined as either a self-reported history of persistent atrial fibrillation or confirmation through electrocardiogram (ECG) results. In addition, transient ischemic attack (TIA) and family history of stroke were considered part of the assessed medical histories.
In the current study, individuals identified as being at high risk for stroke were required to undergo carotid ultrasound examinations. The definition of a high-risk stroke population encompasses individuals who exhibit three or more of the following eight stroke-related risk factors: hypertension, hyperlipidemia, diabetes mellitus, atrial fibrillation, history of smoking, obesity, physical inactivity, and a family history of stroke. Moreover, individuals with a record of TIA or previous stroke episodes also fall within the high-risk category.

2.4 Statistical analysis

The study included 194 878 participants, whose characteristics were evaluated based on the locality of their residence (rural or urban) and gender. In terms of descriptive statistics, categorical variables were displayed as frequencies along with their corresponding percentages, while continuous variables were presented through means accompanied by standard deviations (SDs). Various sociodemographic factors were evaluated, including age (10 year age bands), BMI categories (< 18.5, 18.5–23.9, 24.0–27.9, ≥28.0), educational levels (primary school or below, middle school, high school, college and above), annual income levels (< 5000, 5000–9999, 10 000–19 999, ≥20 000 CNY), and geographical regions (northeast, north, northwest, southwest, south, central, east). The seven geographical regions of China encompassed northeast (Liaoning, Jilin, Heilongjiang), north (Beijing, Tianjin, Hebei, Shanxi, Inner Mongolia), northwest (Shaanxi, Gansu, Qinghai, Ningxia, Xinjiang), southwest (Chongqing, Sichuan, Guizhou, Yunnan, Xizang), south (Guangdong, Guangxi, Hainan), central (Henan, Hubei, Hunan), and east (Shanghai, Jiangsu, Zhejiang, Anhui, Fujian, Jiangxi, Shandong). In addition to these factors, the study examined a range of lifestyle risk factors and medical histories. These risk factors comprised obesity, hypertension, hyperlipidemia, diabetes mellitus, smoking, and alcohol consumption. Meanwhile, the investigated medical histories included stroke, atrial fibrillation, TIA, and family history of stroke.
The study involved an analysis of comprehensive data that concerned individuals with and without carotid plaque, and individuals with and without carotid artery stenosis. In addition, standardized prevalence rates were calculated to assess the prevalence of these conditions across various factors, including age groups, gender, residence, income level, educational level, BMI categories, and geographic location. Sampling weights were applied, incorporating design weights, nonresponse weights, and poststratification weights (Appendix 1 in Supplementary Material). Poststratification weights were specifically calibrated based on several key factors, including residency (distinguishing between rural and urban areas), geographic location (categorized into northeast, north, northwest, southwest, south, central, and east regions), gender (male or female), and age groups (40–49, 50–59, 60–69, 70–79, and 80 years or older). These weights were derived from the reliable data obtained from the 2010 China census. By employing these weighting techniques, this study aimed to ensure the representativeness and generalizability of the findings, accounting for any potential biases that might have arisen from the study design or nonresponse. This approach enhances the validity and robustness of the analysis, allowing for a more accurate estimation of the prevalence rates associated with carotid plaque and artery stenosis under investigation.
Within the analytical framework, we employed various statistical tests to explore relationships and differences within the collected data. For continuous variables, such as age or BMI, we employed t-tests to compare means among different groups. Meanwhile, chi-squared tests were utilized for categorical variables, allowing us to examine associations and dependencies among variables of interest. In addition, logistic regression was applied to calculate odds ratios (ORs) with their corresponding 95% confidence intervals (CIs), facilitating the investigation of associations among lifestyle risk factors, medical histories, and the presence of carotid plaque or artery stenosis. This approach allowed us to quantify the strength and precision of these relationships. By observing varied distributions of carotid artery stenosis and plaque burden among different populations, we further conducted subgroup analyses that focused on major risk factors across age groups (middle-aged individuals, 40 ≤ age < 60, and elders, age ≥ 60), genders (male and female), and the seven geographical regions.
The PROC CORR and PROC REG methods were employed in SAS software to detect multicollinearity among various risk factors. The outcome of PROC CORR revealed that the factors exhibited relatively low correlation coefficients, with the highest being 0.436 (Table S1). Furthermore, tolerance values were found to be greater than 0.1 and the variance inflation factors were less than 10, indicating the absence of multicollinearity among the risk factors analyzed using PROC REG (Table S2).
Data analysis for this study was executed using SAS (version 9.4), while Python (version 3.9.12) was utilized for data visualization. A two-tailed P value of less than 0.05 was recognized as indicating statistical significance.

3 Results

3.1 Overview of study participants

During the study period from 2020 to 2021, 194 878 participants aged 40 years or older underwent ultrasound examination of neck vessels. Among them, 994 (0.5%) were classified as having carotid artery stenosis, while 86 498 (44.4%) had carotid plaque. The characteristics of the participants, stratified by sex and residence, are presented in Tab.1. The mean age of the participants was 63.2 years (SD = 10.6). Females accounted for 54.2% of the participants, and 49.2% resided in urban areas. In addition, 8.2% of the participants had college education or higher, and 43.6% reported an annual income that exceeded 20 000 CNY. The distribution of participants across geographical regions demonstrated variability. East China accounted for the largest proportion of participants, representing 28.5% of the total. By contrast, south China registered the smallest percentage, comprising only 4.1% of the participants.
Tab.1 Demographic profile of the study participants
Characteristics All participants (n = 194 878) Gender, n (%) Residence, n (%)
Male (n = 89 172) Female (n = 105 706) P value Urban (n = 95 872) Rural (n = 99 006) P value
Gender/Residence distribution 45.8% 54.2% < 0.0001 49.2% 50.8% < 0.0001
Mean age, years (SD) 63.2 (10.6) 63.0 (10.7) 63.3 (10.5) < 0.0001 63.1 (10.8) 63.2 (10.3) 0.32
BMI, kg/m2, mean (SD) 25.6 (4.0) 25.6 (3.8) 25.7 (4.1) 0.00 25.6 (3.9) 25.7 (4.0) 0.00
BMI groups, kg/m2, n (%)
< 18.5 2974 (1.5%) 1277 (1.4%) 1697 (1.6%) < 0.0001 1357 (1.4%) 1617 (1.6%) < 0.0001
18.5–23.9 65 552 (33.6%) 28 788 (32.3%) 36 764 (34.8%) 32 252 (33.6%) 33 300 (33.6%)
24.0–27.9 76 912 (39.5%) 37 570 (42.1%) 39 342 (37.2%) 38 356 (40.0%) 38 556 (38.9%)
≥28.0 49 440 (25.4%) 21 537 (24.2%) 27 903 (26.4%) 23 907 (24.9%) 25 533 (25.8%)
Education, n (%)
Primary school or lower 79 888 (41.0%) 29 486 (33.1%) 50 402 (47.7%) < 0.0001 23 529 (24.5%) 56 359 (56.9%) < 0.0001
Junior high school 68 948 (35.4%) 34 210 (38.4%) 34 738 (32.9%) 34 953 (36.5%) 33 995 (34.3%)
High school 30 139 (15.5%) 16 141 (18.1%) 13 998 (13.2%) 23 369 (24.4%) 6770 (6.8%)
College and above 15 903 (8.2%) 9335 (10.5%) 6568 (6.2%) 14 021 (14.6%) 1882 (1.9%)
Annual income, CNY, n (%)
0–5000 52 588 (27.0%) 18 500 (20.7%) 34 088 (32.2%) < 0.0001 14 092 (14.7%) 38 496 (38.9%) < 0.0001
5000–9999 28 795 (14.8%) 12 705 (14.2%) 16 090 (15.2%) 8541(8.9%) 20 254 (20.5%)
10 000–19 999 28 582 (14.7%) 12 919 (14.5%) 15 663 (14.8%) 12 742(13.3%) 15 840 (16.0%)
≥20 000 84 912 (43.6%) 45 047 (50.5%) 39 865 (37.7%) 60 497 (63.1%) 24 415 (24.7%)
Seven geographical regions, n (%)
North 33 180 (17.0%) 14 344 (16.1%) 18 836 (17.8%) < 0.0001 16 186 (16.9%) 16 994 (17.2%) < 0.0001
Northeast 23 410 (12.0%) 9887 (11.1%) 13 523 (12.8%) 10 873 (11.3%) 12 537 (12.7%)
East 55 589 (28.5%) 25 857 (29.0%) 29 732 (28.1%) 28 477 (29.7%) 27 112 (27.4%)
Central 42 338 (21.7%) 19 357 (21.7%) 22 981 (21.7%) 20 020 (20.9%) 22 318 (22.5%)
South 7965 (4.1%) 3972 (4.5%) 3993 (3.8%) 5070 (5.3%) 2895 (2.9%)
Southwest 17 057 (8.8%) 8365 (9.4%) 8692 (8.2%) 10 337 (10.8%) 6720 (6.8%)
Northwest 15 339 (7.9%) 7390 (8.3%) 7949 (7.5%) 4909 (5.1%) 10 430 (10.5%)
Risk factors, n (%)
Obesity 49 440 (25.4%) 21 537 (24.2%) 27 903 (26.4%) < 0.0001 23 907 (24.9%) 25 533 (25.8%) < 0.0001
Hypertension 136 146 (69.9%) 63 184 (70.9%) 72 962 (69.0%) < 0.0001 66 966 (69.8%) 69 180 (69.9%) 0.90
Diabetes mellitus 64 950 (33.3%) 28 648 (32.1%) 36 302 (34.3%) < 0.0001 34 554 (36.0%) 30 396 (30.7%) < 0.0001
Hyperlipidemia 113 025 (58.0%) 52 191 (58.5%) 60 834 (57.6%) < 0.0001 58 747 (61.3%) 54 278 (54.8%) < 0.0001
Stroke 18 533 (9.5%) 9410 (10.6%) 9123 (8.6%) < 0.0001 9495 (9.9%) 9038 (9.1%) < 0.0001
TIA 5335 (2.7%) 2211 (2.5%) 3124 (3.0%) < 0.0001 2451 (2.6%) 2884 (2.9%) < 0.0001
Atrial fibrillation 3620 (1.9%) 1649 (1.8%) 1971 (1.9%) 0.80 1965 (2.0%) 1655 (1.7%) < 0.0001
Smoking 40 478 (20.8%) 38 111 (42.7%) 2367 (2.2%) < 0.0001 19 038 (19.9%) 21 440 (21.7%) < 0.0001
Drinking 39 372 (20.2%) 34 611 (38.8%) 4761 (4.5%) < 0.0001 20 821 (21.7%) 18 551 (18.7%) < 0.0001
Family history of stroke 35 431 (18.2%) 15 692 (17.6%) 19 739 (18.7%) < 0.0001 19 418 (20.3%) 16 013(16.2%) < 0.0001
Laboratory test, mean (SD)
Systolic blood pressure, mm Hg 137.9 (18.2) 137.8 (17.4) 138.0 (18.9) 0.03 136.0 (17.5) 139.7 (18.8) < 0.0001
Diastolic blood pressure, mm Hg 82.9 (10.6) 84.2 (10.8) 81.8 (10.4) < 0.0001 82.4 (10.5) 83.4 (10.8) < 0.0001
Total cholesterol, mmol/L 4.8 (1.3) 4.6 (1.2) 5.0 (1.3) < 0.0001 4.8 (1.3) 4.8 (1.3) 0.10
HDL cholesterol, mmol/L 1.4 (0.6) 1.4 (0.6) 1.5 (0.6) < 0.0001 1.4 (0.5) 1.5 (0.6) < 0.0001
Fasting plasma glucose, mmol/L 5.8 (2.1) 5.7 (2.0) 5.8 (2.1) < 0.0001 5.9 (2.0) 5.7 (2.1) < 0.0001
Homocysteine, µmol/L 15.8 (8.9) 17.5 (10.0) 14.3 (7.6) < 0.0001 15.1 (8.3) 16.4 (9.4) < 0.0001
Glycated hemoglobin (HbA1c) 5.8 (1.4) 5.8 (1.4) 5.8 (1.4) 0.50 5.8 (1.4) 5.7 (1.4) < 0.0001
The detailed demographic characteristics of individuals diagnosed with or without carotid artery stenosis and plaque are presented in Table S3. Among the 994 individuals diagnosed with carotid artery stenosis, the average age was significantly higher (mean 70.6 years, SD = 9.1) compared with those without carotid artery stenosis (mean 63.1 years, SD = 10.6). Furthermore, 872 (87.7%) of these individuals were aged 60 years or older, a proportion that significantly exceeded the 60.0% observed in the non-affected cohort. In addition, among the 86 498 patients with carotid plaque, 65 340 (75.6%) were aged 60 years or older, a rate that was notably higher than the 47.9% found among those without carotid plaque.

3.2 Standard prevalence of carotid artery stenosis and plaque

After adjustments by using the 2010 China standard population and other factors, the standardized prevalence rates for carotid artery stenosis and plaque in adults over 40 years were 0.40% (95% CI, 0.37%–0.42%) and 36.27% (95% CI, 36.05%–36.48%), respectively (Tab.2). Significant age-related correlations were observed, with higher prevalence rates in older age brackets. Gender disparities were also notable. Males exhibited higher standardized prevalence rates for carotid artery stenosis (0.46%; 95% CI, 0.42%–0.51%) and plaque (38.44%; 95% CI, 38.12%–38.76%) compared with females (0.31%; 95% CI, 0.28%–0.35% for stenosis and 33.51%; 95% CI, 33.23%–33.80% for plaque). This trend persisted across all age groups, as illustrated in Fig.2. In addition, carotid plaque prevalence was higher among individuals with urban residence (37.82%; 95% CI, 37.51%–38.13%), lower annual income (41.41%; 95% CI, 40.99%–41.83%), lower educational level (41.39%; 95% CI, 41.05%–41.73%), lower BMI (43.91%; 95% CI, 42.12%–45.69%), and various health conditions, including hypertension (42.47%; 95% CI, 42.20%–42.73%), diabetes mellitus (42.05%; 95% CI, 41.67%–42.43%), hyperlipidemia (37.73%; 95% CI, 37.43%–38.00%), stroke (59.59%; 95% CI, 58.88%–60.29%), TIA (43.26%; 95% CI, 41.93%–44.59%), atrial fibrillation (48.59%; 95% CI, 46.97%–50.22%), smoking (40.03%; 95% CI, 39.55%–40.51%), and alcohol consumption (37.57%; 95% CI, 37.10%–38.05%).
Tab.2 Standardized prevalence of carotid artery stenosis and plaque among Chinese adults aged 40+ years
Characteristics Carotid artery stenosis Carotid plaque
Participants No. Events No. Standardized prevalence, % (95% CI) P value Participants No. Events No. Standardized prevalence, % (95% CI) P value
Overall 194 878 994 0.40 (0.37–0.42) 194 878 86 498 36.27 (36.05–36.48)
Age group, year
40–49 21 359 14 0.06 (0.02–0.09) < 0.0001 21 359 3586 15.66 (15.17–16.14) < 0.0001
50–59 56 269 108 0.22 (0.18–0.26) 56 269 17 572 31.20 (30.82–31.59)
60–69 59 522 299 0.50 (0.44–0.55) 59 522 30 180 50.30 (49.89–50.70)
70–79 45 521 416 1.01 (0.92–1.10) 45 521 27 582 61.14 (60.71–61.60)
80+ 12 207 157 1.48 (1.27–1.69) 12 207 7578 62.78 (61.92–63.63)
Gender
Male 89 172 599 0.46 (0.42–0.51) < 0.0001 89 172 43 002 38.44 (38.12–38.76) < 0.0001
Female 105 706 395 0.31 (0.28–0.35) 105 706 43 496 33.51 (33.23–33.80)
Residence
Urban 95 872 513 0.43 (0.39–0.47) 0.13 95 872 44 255 37.82 (37.51–38.13) < 0.0001
Rural 99 006 481 0.37 (0.34–0.41) 99 006 42 243 35.31 (35.02–35.61)
Annual income, CNY
0–5000 52 588 306 0.53 (0.46–0.59) 0.05 52 588 24 730 41.41 (40.99–41.83) < 0.0001
5000–9999 28 795 142 0.37 (0.30–0.44) 28 795 12 486 36.72 (36.15–37.26)
10 000–19 999 28 582 132 0.36 (0.29–0.42) 28 582 12 470 36.51 (35.94–37.05)
≥20 000 84 913 414 0.34 (0.30–0.38) 84 913 36 812 33.02 (32.71–33.34)
Education
Primary school or lower 79 888 428 0.46 (0.41–0.50) 0.30 79 888 38 040 41.39 (41.05–41.73) < 0.0001
Junior high school 68 948 351 0.37 (0.32–0.41) 68 948 29 046 33.19 (32.85–33.55)
High school 30 139 148 0.36 (0.29–0.42) 30 139 13 524 35.63 (35.08–36.16)
College and above 15 903 67 0.32 (0.23–0.41) 15 903 5888 28.53 (27.83–29.24)
BMI groups
< 18.5 2974 27 0.84 (0.51–1.17) < 0.0001 2974 1491 43.91 (42.12–45.69) < 0.0001
18.5–23.9 65 552 378 0.46 (0.41–0.51) 65 552 29 103 36.31 (35.94–36.68)
24.0–27.9 76 912 384 0.39 (0.34–0.43) 76 912 34 747 37.03 (36.69–37.37)
≥28.0 49 440 205 0.31 (0.26–0.36) 49 440 21 157 34.66 (34.25–35.09)
Seven geographical regions
North 33 180 215 0.61 (0.53–0.70) < 0.0001 33 180 15 709 40.84 (40.32–41.38) < 0.0001
Northeast 23 410 166 0.53 (0.44–0.63) 23 410 11 532 39.37 (38.75–40.00)
East 55 589 228 0.33 (0.28–0.37) 55 589 23 092 32.43 (32.04–32.82)
Central 42 338 170 0.33 (0.28–0.39) 42 338 17 431 34.12 (33.68–34.59)
South 7965 78 0.61 (0.44–0.78) 7965 3244 31.68 (30.66–32.70)
Southwest 17 057 67 0.23 (0.16–0.30) 17 057 8659 43.17 (42.43–43.92)
Northwest 15 339 70 0.36 (0.27–0.46) 15 339 6831 35.92 (35.15–36.67)
Obesity
Yes 49 440 205 0.31 (0.26–0.36) 0.00 49 440 21 157 34.66 (34.25–35.09) < 0.0001
No 145 438 789 0.43 (0.39–0.46) 145 438 65 341 36.85 (36.59–37.09)
Hypertension
Yes 136 146 795 0.48 (0.45–0.52) < 0.0001 136 146 66 787 42.47 (42.20–42.73) < 0.0001
No 58 732 199 0.24 (0.20–0.28) 58 732 19 711 25.46 (25.12–25.82)
Diabetes mellitus
Yes 64 950 412 0.54 (0.48–0.60) < 0.0001 64 950 32 050 42.05 (41.67–42.43) < 0.0001
No 129 928 582 0.34 (0.31–0.37) 129 928 54 448 33.94 (33.69–34.20)
Hyperlipidemia
Yes 113 025 581 0.39 (0.35–0.42) 0.77 113 025 51 909 37.73 (37.43–38.00) < 0.0001
No 81 853 413 0.41 (0.36–0.45) 81 853 34 589 34.41 (34.08–34.73)
Stroke
Yes 18 533 230 1.15 (1.00–1.31) < 0.0001 18 533 11 428 59.59 (58.88–60.29) < 0.0001
No 176 345 764 0.34 (0.31–0.37) 176 345 75 070 34.53 (34.31–34.76)
TIA
Yes 5335 33 0.46 (0.28–0.64) 0.26 5335 2686 43.26 (41.93–44.59) < 0.0001
No 189 543 961 0.39 (0.37–0.42) 189 543 83 812 36.09 (35.89–36.32)
Atrial fibrillation
Yes 3620 35 0.71 (0.44–0.99) < 0.0001 3620 1985 48.59 (46.97–50.22) < 0.0001
No 191 258 959 0.39 (0.36–0.42) 191 258 84 513 36.08 (35.87–36.30)
Smoking
Yes 40 478 272 0.46 (0.40–0.53) < 0.0001 40 478 19 934 40.03 (39.55–40.51) < 0.0001
No 154 400 722 0.37 (0.34–0.40) 154 400 66 564 34.88 (34.65–35.12)
Drinking
Yes 39 372 206 0.39 (0.32–0.45) 0.68 39 372 18 444 37.57 (37.10–38.05) < 0.0001
No 155 506 788 0.40 (0.37–0.43) 155 506 68 054 35.80 (35.56–36.03)
Family history of stroke
Yes 35 431 184 0.39 (0.32–0.45) 0.79 35 431 16 766 39.74 (39.24–40.26) < 0.0001
No 159 447 810 0.40 (0.37–0.43) 159 447 69 732 35.52 (35.29–35.76)
Fig.2 Standardized prevalence of carotid artery stenosis (A) and carotid plaque (B) by age groups.

Full size|PPT slide

Geographic disparities in the prevalence of carotid artery stenosis and plaque were apparent. The north (0.61%; 95% CI, 0.53%–0.70%) and south (0.61%; 95% CI, 0.44%–0.78%) exhibited the highest rates of carotid artery stenosis, followed by the northeast (0.53%; 95% CI, 0.44%–0.63%), northwest (0.36%; 95% CI, 0.27%–0.46%), central (0.33%; 95% CI, 0.28%–0.39%), east (0.33%; 95% CI, 0.28%–0.37%), and southwest (0.23%; 95% CI, 0.16%–0.30%) (Fig.3). Conversely, while the southwest displayed the highest incidence of carotid plaque, the south had the lowest. A province-level analysis might not yield meaningful insights due to the relatively low prevalence of carotid artery stenosis and the incomplete data from some provinces. Therefore, we focused our further analysis on the prevalence of carotid artery plaque across provinces. Significant regional disparities in the standardized prevalence of carotid plaque were evident across China’s 31 provinces (Table S4). Yunnan recorded the highest prevalence at 56.3%, in stark contrast with Qinghai’s lowest at 8.3%. These differences may be attributed to varying lifestyle habits and disparities in sample sizes among regions.
Fig.3 Standardized prevalence of carotid artery stenosis (A) and carotid plaque (B) by regions.

Full size|PPT slide

3.3 Risk factor analysis

Logistic regression was employed to explore the relationships between potential risk factors and the onset of carotid artery stenosis and plaque formation. The results, which are outlined in Tab.3, revealed diverse correlations in terms of direction and strength. Factors, such as hypertension (OR = 1.23, 95% CI = 1.05–1.45), diabetes mellitus (OR = 1.28, 95% CI = 1.12–1.45), stroke (OR = 2.01, 95% CI = 1.72–2.33), atrial fibrillation (OR = 1.46, 95% CI = 1.02–2.01), and smoking (OR = 1.44, 95% CI = 1.22–1.70) consistently demonstrated an association with a higher risk of carotid artery stenosis, with stroke exhibiting the most potent link. Conversely, obesity (OR = 0.91, 95% CI = 0.77–1.06), hyperlipidemia (OR = 1.05, 95% CI = 0.92–1.20), TIA (OR = 1.23, 95% CI = 0.85–1.71), alcohol consumption (OR = 0.88, 95% CI = 0.74–1.04), and a family history of stroke (OR = 1.11, 95% CI = 0.94–1.30) showed no significant associations with carotid artery stenosis. For carotid plaque, a wide range of risk factors emerged, including hypertension, diabetes, hyperlipidemia, stroke, TIA, atrial fibrillation, smoking, drinking, and a family history of stroke, with stroke showing the strongest association (OR = 2.17, 95% CI = 2.10–2.24). However, obesity appeared to provide some protection (OR = 0.92, 95% CI = 0.90–0.94). These findings suggested the need for further analysis in specific subgroups.
Tab.3 ORs for carotid artery stenosis and plaque
Characteristics Carotid artery stenosis (n = 8689) Carotid plaque (n = 86 498)
OR (95% CI) P value OR (95% CI) P value
Age group, year
40–49 1 (reference) 1 (reference)
50–59 2.87 (1.70–5.25) < 0.0001 2.25 (2.16–2.34) < 0.0001
60–69 6.74 (4.08–12.14) < 0.0001 5.10 (4.90–5.30) < 0.0001
70–79 12.59 (7.62–22.68) < 0.0001 7.62 (7.32–7.94) < 0.0001
80+ 18.84 (11.20–34.39) < 0.0001 8.11 (7.71–8.54) < 0.0001
Gender
Male 1 (reference) 1 (reference)
Female 0.60 (0.52–0.70) < 0.0001 0.75 (0.74–0.76) < 0.0001
Residence
Urban 1 (reference) 1 (reference)
Rural 0.93 (0.80–1.08) 0.31 0.87 (0.85–0.88) < 0.0001
Education
Primary school or lower 1 (reference) 1 (reference)
Junior high school 1.18 (1.00–1.38) 0.26 0.80 (0.79–0.82) < 0.0001
High school 1.12 (0.90–1.39) 0.84 0.90 (0.87–0.92) < 0.0001
College and above 1.12 (0.83–1.49) 0.87 0.65 (0.62–0.67) < 0.0001
Annual income, CNY
0–5000 1 (reference) 1 (reference)
5000–9999 0.90 (0.73–1.09) 0.86 0.86 (0.84–0.89) < 0.0001
10 000–19 999 0.86 (0.70–1.07) 0.50 0.87 (0.85–0.90) 0.00
≥20 000 0.87 (0.73–1.05) 0.53 0.86 (0.84–0.88) < 0.0001
7 Geographical regions
North 0.71 (0.55–0.93) 0.00 0.87 (0.84–0.91) < 0.0001
Northeast 0.80 (0.61–1.05) 0.50 0.94 (0.91–0.98) < 0.0001
East 0.37 (0.29–0.49) < 0.0001 0.69 (0.67–0.71) < 0.0001
Central 0.41 (0.32–0.54) < 0.0001 0.68 (0.66–0.70) < 0.0001
South 1 (reference) 0.67 (0.63–0.70) < 0.0001
Southwest 0.36 (0.26–0.50) < 0.0001 1 (reference)
Northwest 0.52 (0.37–0.72) < 0.0001 0.78 (0.75–0.81) < 0.0001
Risk factors
Obesity
No 1 (reference) 1 (reference)
Yes 0.91 (0.77–1.06) 0.22 0.92 (0.90–0.94) < 0.0001
Hypertension
No 1 (reference) 1 (reference)
Yes 1.23 (1.05–1.45) 0.01 1.91 (1.87–1.95) < 0.0001
Diabetes mellitus
No 1 (reference) 1 (reference)
Yes 1.28 (1.12–1.45) 0.00 1.35 (1.33–1.38) < 0.0001
Hyperlipidemia
No 1 (reference) 1 (reference)
Yes 1.05 (0.92–1.20) 0.44 1.16 (1.14–1.18) < 0.0001
Stroke
No 1 (reference) 1 (reference)
Yes 2.01 (1.72–2.33) < 0.0001 2.17 (2.10–2.24) < 0.0001
TIA
No 1 (reference) 1 (reference)
Yes 1.23 (0.85–1.71) 0.26 1.28 (1.21–1.35) < 0.0001
Atrial fibrillation
No 1 (reference) 1 (reference)
Yes 1.46 (1.02–2.01) 0.03 1.53 (1.44–1.64) < 0.0001
Smoking
No 1 (reference) 1 (reference)
Yes 1.44 (1.22–1.70) < 0.0001 1.28 (1.25–1.31) < 0.0001
Drinking
No 1 (reference) 1 (reference)
Yes 0.88 (0.74–1.04) 0.13 1.13 (1.11–1.16) < 0.0001
Family history of stroke
No 1 (reference) 1 (reference)
Yes 1.11 (0.94–1.30) 0.23 1.16 (1.13–1.18) < 0.0001

3.4 Subgroup analysis

We conducted further subgroup analyses by age, gender, and geographical regions (Tab.4 and Tab.5). The results appeared significant. Among participants aged 60 years and older, the major risk factors were largely consistent with those observed in the overall population. However, for patients under 60 years, stroke was the only risk factor for carotid artery stenosis, with an OR of 3.87 (95% CI = 2.25–6.28). For carotid plaque, multiple risk factors were identified across both age groups: hypertension (OR = 1.68, 95% CI = 1.63–1.74), diabetes mellitus (OR = 1.33, 95% CI = 1.28–1.38), hyperlipidemia (OR = 1.30, 95% CI = 1.26–1.35), stroke (OR = 2.25, 95% CI = 2.09–2.42), TIA (OR = 1.27, 95% CI = 1.14–1.41), family history of stroke (OR = 1.37, 95% CI = 1.31–1.42), smoking (OR = 1.29, 95% CI = 1.23–1.34), and drinking (OR = 1.11, 95% CI = 1.07–1.16). In the gender-specific analysis, for males, significant risk factors for carotid artery stenosis included diabetes mellitus (OR = 1.28, 95% CI = 1.08–1.51), stroke (OR = 2.07, 95% CI = 1.70–2.51), and smoking (OR = 1.29, 95% CI = 1.23–1.34). For females, significant risk factors were hypertension (OR = 1.47, 95% CI = 1.12–1.96), diabetes mellitus (OR = 1.23, 95% CI = 1.00–1.51), stroke (OR = 2.02, 95% CI = 1.56–2.57), atrial fibrillation (OR = 1.96, 95% CI = 1.19–3.03), and smoking (OR = 1.79, 95% CI = 1.01–2.93). Neither obesity (OR = 1.00, 95% CI = 0.97–1.03) nor alcohol consumption (OR = 0.97, 95% CI = 0.91–1.03) were associated with carotid plaque in females. Conversely, obesity displayed potential protective effects against carotid artery stenosis (OR = 0.84, 95% CI = 0.71–0.99) and plaque (OR = 0.94, 95% CI = 0.92–0.97) among participants aged 60 years and older.
Tab.4 Risk factor analysis of carotid artery stenosis and plaque by age and gender
Risk factors Participants aged < 60 years Participants aged ≥60 years Male Female
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
For carotid artery stenosis
Hypertension 1.31 (0.89–1.96) 0.18 1.27 (1.07–1.51) 0.01 1.09 (0.90–1.33) 0.38 1.47 (1.12–1.96) 0.01
Diabetes mellitus 1.23 (0.82–1.79) 0.30 1.28 (1.11–1.46) 0.00 1.28 (1.08–1.51) 0.00 1.23 (1.00–1.51) 0.04
Hyperlipidemia 0.94 (0.65–1.36) 0.72 1.03 (0.90–1.18) 0.71 1.00 (0.85–1.18) 0.98 1.12 (0.91–1.38) 0.31
Obesity 0.91 (0.59–1.36) 0.65 0.84 (0.71–0.99) 0.04 0.83 (0.66–1.02) 0.08 1.01 (0.80–1.27) 0.91
Stroke 3.87 (2.25–6.28) < 0.0001 2.17 (1.85–1.54) < 0.0001 2.07 (1.70–2.51) < 0.0001 2.02 (1.56–2.57) < 0.0001
TIA 0.75 (0.12–2.36) 0.69 1.27 (0.87–1.79) 0.19 1.01 (0.59–1.61) 0.96 1.45 (0.85–2.29) 0.14
Atrial fibrillation 1.52 (0.25–4.81) 0.56 1.58 (1.09–2.21) 0.01 1.10 (0.64–1.75) 0.72 1.96 (1.19–3.03) 0.00
Family history of stroke 1.27 (0.83–1.89) 0.25 0.98 (0.82–1.17) 0.84 1.03 (0.82–1.27) 0.81 1.17 (0.91–1.50) 0.21
Smoking 1.38 (0.88–2.13) 0.15 1.71 (1.44–2.01) < 0.0001 1.34 (1.12–1.59) 0.00 1.79 (1.01–2.93) 0.03
Drinking 1.16 (0.73–1.79) 0.52 0.94 (0.78–1.13) 0.52 0.87 (0.72–1.04) 0.13 0.98 (0.56–1.58) 0.94
For carotid plaque
Hypertension 1.68 (1.63–1.74) < 0.0001 1.47 (1.43–1.51) < 0.0001 1.44 (1.40–1.49) < 0.0001 1.50 (1.45–1.55) < 0.0001
Diabetes mellitus 1.33 (1.28–1.38) < 0.0001 1.14 (1.11–1.17) < 0.0001 1.15 (1.12–1.19) < 0.0001 1.18 (1.15–1.21) < 0.0001
Hyperlipidemia 1.30 (1.26–1.35) < 0.0001 1.09 (1.06–1.11) < 0.0001 1.07 (1.04–1.10) < 0.0001 1.23 (1.19–1.26) < 0.0001
Obesity 1.03 (0.99–1.07) 0.10 0.94 (0.92–0.97) < 0.0001 0.96 (0.93–0.99) 0.02 1.00 (0.97–1.03) 0.97
Stroke 2.25 (2.09–2.42) < 0.0001 1.53 (1.47–1.58) < 0.0001 1.63 (1.55–1.70) < 0.0001 1.50 (1.43–1.57) < 0.0001
TIA 1.27 (1.14–1.41) < 0.0001 1.17 (1.10–1.25) < 0.0001 1.15 (1.05–1.26) 0.00 1.19 (1.10–1.28) < 0.0001
Atrial fibrillation 1.15 (0.99–1.34) 0.07 1.29 (1.20–1.40) < 0.0001 1.16 (1.05–1.29) 0.00 1.26 (1.14–1.38) < 0.0001
Family history of stroke 1.37 (1.31–1.42) < 0.0001 1.21 (1.17–1.25) < 0.0001 1.25 (1.21–1.30) < 0.0001 1.32 (1.27–1.36) < 0.0001
Smoking 1.29 (1.23–1.34) < 0.0001 1.19 (1.15–1.23) < 0.0001 1.28 (1.24–1.31) < 0.0001 1.33 (1.22–1.45) < 0.0001
Drinking 1.11 (1.07–1.16) < 0.0001 1.11 (1.07–1.15) < 0.0001 1.18 (1.15–1.22) < 0.0001 0.97 (0.91–1.03) 0.3597
Tab.5 Region-specific risk factor analysis of carotid artery stenosis and plaque
Risk factors North (n = 33 180) Northeast (n = 23 410) East (n = 55 589) Central (n = 42 338) South (n = 7965) Southwest (n = 17 057) Northwest (n = 15 339)
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
For carotid artery stenosis
Male 1.78 (1.35–2.35) < 0.0001 1.81 (1.33–2.47) 0.00 2.53 (1.92–3.37) < 0.0001 1.68 (1.23–2.29) 0.00 0.85 (0.54–1.33) 0.47 1.89 (1.15–3.19) 0.01 3.51 (2.06–6.29) < 0.0001
Aged ≥60 years 5.45 (3.69–8.38) < 0.0001 2.30 (1.59–3.41) < 0.0001 6.14 (3.88–10.36) < 0.0001 6.11 (3.86–10.22) < 0.0001 13.63 (6.06–38.99) < 0.0001 6.09 (2.84–15.83) < 0.0001 3.19 (1.75–6.32) 0.00
< 5000 CNY annual income 1.16 (0.84–1.58) 0.37 0.86 (0.55–1.29) 0.47 1.65 (1.24–2.20) 0.00 1.14 (0.84–1.61) 0.45 0.76 (0.38–1.42) 0.42 0.65 (0.34–1.18) 0.18 1.63 (0.96–2.75) 0.07
Hypertension 1.06 (0.76–1.50) 0.76 1.07 (0.77–1.51) 0.69 1.66 (1.12–2.54) 0.02 1.63 (1.12–2.44) 0.01 0.76 (0.45–1.33) 0.31 2.77 (1.29–7.20) 0.02 1.80 (1.04–3.30) 0.04
Diabetes mellitus 1.44 (1.09–1.89) 0.01 0.95 (0.67–1.34) 0.78 1.35 (1.03–1.76) 0.03 1.37 (1.01–1.87) 0.04 1.29 (0.81–2.06) 0.28 1.34 (0.82–2.20) 0.24 1.65 (1.00–2.67) 0.04
Hyperlipidemia 1.09 (0.82–1.45) 0.56 0.88 (0.64–1.20) 0.41 1.13 (0.86–1.49) 0.37 0.98 (0.72–1.34) 0.88 1.22 (0.73–2.12) 0.47 1.10 (0.66–1.87) 0.72 1.15 (0.71–1.90) 0.58
Obesity 0.76 (0.54–1.05) 0.11 1.01 (0.66–1.49) 0.97 1.04 (0.76–1.42) 0.79 0.73 (0.46–1.09) 0.14 1.26 (0.72–2.14) 0.40 0.90 (0.49–1.57) 0.73 0.86 (0.48–1.49) 0.61
Stroke 2.84 (2.09–3.82) < 0.0001 1.30 (0.81–2.01) 0.25 2.17 (1.58–2.93) < 0.0001 1.39 (0.89–2.09) 0.13 1.65 (0.91–2.86) 0.09 6.34 (3.72–10.62) < 0.0001 1.68 (0.77–3.24) 0.15
TIA 1.74 (0.93–2.98) 0.06 0.83 (0.20–2.20) 0.74 1.06 (0.48–2.03) 0.87 1.13 (0.35–2.69) 0.81 2.81 (0.82–7.21) 0.06 0.56 (0.03–2.58) 0.49 1.26 (0.39–2.98) 0.65
Atrial fibrillation 1.13 (0.44–2.35) 0.78 0.65 (0.11–2.07) 0.55 1.59 (0.78–2.88) 0.16 1.78 (0.70–3.73) 0.17 2.01 (0.59–5.15) 0.19 3.41 (1.18–7.86) 0.01 1.44 (0.23–4.64) 0.62
Family history of stroke 1.17 (0.84–1.60) 0.35 0.70 (0.42–1.11) 0.15 1.10 (0.78–1.51) 0.57 0.70 (0.43–1.08) 0.13 2.51 (1.54–4.04) 0.00 0.79 (0.35–1.57) 0.54 1.08 (0.45–2.21) 0.86
For carotid plaque
Male 1.81 (1.73–1.90) < 0.0001 1.52 (1.43–1.60) < 0.0001 1.39 (1.34–1.44) < 0.0001 1.30 (1.25–1.36) < 0.0001 1.29 (1.17–1.42) < 0.0001 1.16 (1.09–1.24) < 0.0001 1.26 (1.18–1.35) < 0.0001
Aged ≥60 years 4.14 (3.94–4.34) < 0.0001 3.06 (2.89–3.24) < 0.0001 3.55 (3.41–3.70) < 0.0001 3.74 (3.57–3.91) < 0.0001 3.77 (3.40–4.17) < 0.0001 2.30 (2.15–2.45) < 0.0001 3.27 (3.04–3.51) < 0.0001
< 5000 CNY annual income 0.99 (0.94–1.05) 0.75 1.28 (1.18–1.38) < 0.0001 1.03 (0.99–1.08) 0.14 0.83 (0.79–0.87) < 0.0001 0.88 (0.78–1.00) 0.05 1.44 (1.33–1.55) < 0.0001 0.95 (0.88–1.03) 0.22
Hypertension 1.80 (1.71–1.89) < 0.0001 1.84 (1.74–1.94) < 0.0001 2.02 (1.93–2.11) < 0.0001 1.89 (1.81–1.98) < 0.0001 1.71 (1.53–1.91) < 0.0001 1.15 (1.07–1.24) 0.00 1.32 (1.23–1.43) < 0.0001
Diabetes 1.44 (1.37–1.51) < 0.0001 1.11 (1.05–1.18) 0.0004 1.35 (1.30–1.40) < 0.0001 1.31 (1.25–1.37) < 0.0001 1.32 (1.20–1.46) < 0.0001 1.01 (0.95–1.08) 0.68 1.13 (1.04–1.22) 0.00
Hyperlipidemia 1.26 (1.20–1.32) < 0.0001 1.04 (0.98–1.09) 0.21 1.25 (1.21–1.30) < 0.0001 1.04 (0.99–1.08) 0.0802 1.14 (1.03–1.26) 0.01 0.76 (0.71–0.81) < 0.0001 0.91 (0.84–0.97) 0.01
Obesity 0.84 (0.80–0.88) < 0.0001 0.82 (0.77–0.88) < 0.0001 0.95 (0.91–0.99) 0.01 0.86 (0.82–0.90) < 0.0001 0.79 (0.71–0.88) < 0.0001 0.73 (0.69–0.78) < 0.0001 0.99 (0.92–1.08) 0.88
Stroke 2.09 (1.94–2.26) < 0.0001 1.60 (1.47–1.76) < 0.0001 2.23 (2.10–2.36) < 0.0001 1.83 (1.70–1.96) < 0.0001 2.37 (2.03–2.77) < 0.0001 1.55 (1.39–1.73) < 0.0001 1.62 (1.42–1.84) < 0.0001
TIA 1.44 (1.26–1.65) < 0.0001 1.12 (0.95–1.34) 0.19 1.34 (1.22–1.47) < 0.0001 1.25 (1.09–1.44) 0.00 1.26 (0.92–1.72) 0.16 1.20 (1.02–1.41) 0.02 1.18 (0.93–1.50) 0.18
Atrial fibrillation 1.20 (1.01–1.43) 0.04 1.06 (0.85–1.31) 0.63 1.17 (1.03–1.33) 0.01 1.08 (0.92–1.26) 0.37 1.27 (0.88–1.83) 0.20 1.06 (0.86–1.32) 0.58 1.08 (0.84–1.38) 0.55
Family history of stroke 1.26 (1.19–1.33) < 0.0001 1.07 (0.99–1.15) 0.05 1.17 (1.12–1.22) < 0.0001 0.96 (0.91–1.01) 0.14 0.95 (0.84–1.07) 0.39 0.96 (0.88–1.04) 0.33 1.23 (1.09–1.39) 0.00
Region-specific analysis revealed distinct patterns of risk factors across all seven regions. Advanced age (≥60 years) was identified as a risk factor for carotid artery stenosis and plaque in all the regions. The male gender increased the risk of carotid artery stenosis in the north, northeast, east, central, southwest, and northwest, and heightened the risk of carotid plaque across all the regions. In addition, a lower income (< 5000 CNY annually) was associated with an increased risk of carotid stenosis in the east and carotid plaque in the northeast and southwest. Hypertension was a significant risk factor for carotid artery stenosis in the east, central, southwest, and northwest. Similarly, diabetes mellitus escalated the risk of carotid artery stenosis in the north, east, central, and northwest, while stroke was linked to carotid artery stenosis in the north, east, and southwest. Atrial fibrillation increased the risk of carotid artery stenosis in the southwest, and a family history of stroke was particularly critical in the south. With regard to carotid plaque, hypertension and stroke were identified as risk factors in all seven regions. Diabetes was linked to carotid plaque in nearly all the regions except the southwest. In addition, the association between carotid plaque and TIA was significant in the north, east, central, and southwest regions. Atrial fibrillation was a significant risk factor in the north and east. Moreover, a family history of stroke was associated with a higher risk of developing carotid plaque in the north, east, and northwest.

4 Discussion

In contrast with earlier studies in China that employed smaller samples, this cross-sectional research presents a pioneering nationwide analysis of the prevalence of carotid artery plaque and stenosis. Encompassing 31 provinces, our study specifically targets a substantial cohort of individuals with an elevated risk of stroke.
From 2020 to 2021, the standardized prevalence of carotid artery plaque among Chinese adults over 40 years was 36.27%, while that for stenosis was 0.40%. These results were compared with the 2020 Lancet Global Health review, which reported global prevalences for the 30–79 age group of 21.1% for plaque and 1.5% for stenosis, indicating a higher prevalence of plaque and a lower prevalence of stenosis in our study [18]. Previous studies have indicated a general population prevalence rate of carotid artery stenosis that ranged from 0.56% to 6%, which are higher than our findings [1922]. In addition, a study in northeast China identified a prevalence of carotid plaque at 40.0%, which closely aligned with our study’s prevalence of 39.37% in the same region. Another Chinese study noted a 31% prevalence for carotid plaque [23], which was slightly below our results. By contrast, a rural Chinese study reported a prevalence of 41.5% [24], which was slightly higher than our rural findings of 35.31%. These variations can arise from different definitions of carotid artery plaque and stenosis, variations in study design, and varying age distributions among study populations. However, our comprehensive sampling and larger sample size potentially yield more accurate results.
Our research suggests that carotid artery stenosis and plaque are more prevalent among males, the elderly, and individuals with conditions, such as hypertension, diabetes, stroke, atrial fibrillation, and smokers. These findings are consistent with previous studies [2530]. Hypertension is a risk factor for both carotid conditions, potentially due to the pro-inflammatory and pro-oxidative effects of angiotensin II [31]. Diabetes elevates the risk for carotid artery stenosis and plaque, possibly because of its adverse effects on cerebrovascular circulation, similar to its effect on coronary and leg arteries [29]. In our study, hyperlipidemia is identified as a risk factor for carotid plaque due to its role in accelerating atherosclerotic plaque development through cholesterol deposition, heightened inflammation, and oxidative stress [32]. However, our findings do not show a significant relationship between hyperlipidemia and carotid artery stenosis, potentially due to the multifactorial nature of stenosis that may obscure hyperlipidemia’s effect.
Our data did not show a direct link between alcohol consumption and carotid stenosis, although alcohol was associated with the risk of carotid plaque. Previous research on alcohol and carotid stenosis has been inconclusive; while moderate drinking may have a protective effect [33], heavy drinking may accelerate atherosclerosis [34]. Given our study’s disadvantages in capturing alcohol quantity, further investigation is necessary to clarify these relationships. In our study, obesity demonstrated a protective role against carotid stenosis and plaque in older adults (age ≥60 years) and in males with carotid plaque. This observation may be explained by the “survival effect”, wherein overweight individuals who reach old age may possess traits that protect them from adverse effects that are typically associated with excess weight [35]. In addition, the potential confounding effects of more comprehensive medical management of cardiovascular risk factors in obese individuals may also explain the observed protective effects. Previous research on the relationship between obesity and carotid atherosclerosis has reported mixed results. Some studies suggest that obesity and related measures are not associated with the severity of carotid artery stenosis and plaque [36,37]. However, a study on Chinese adults indicated that different obese phenotypes might increase the risk of carotid artery plaque [38], while another research that involved 750 individuals concluded that the prevalence of carotid artery plaque was inversely related to BMI [39]. A deeper analysis of the genetic factors or a targeted cohort study may provide a more definitive understanding of the relationship between obesity and carotid atherosclerosis.
Furthermore, our findings indicate that lower educational and income levels are potential risk factors for carotid plaque. This finding is consistent with the results of Bi et al. [40] and Zhang et al. [41]. It suggests that individuals with higher education and income levels may have greater health awareness and access to superior medical care, leading to lower detection rates of carotid plaque. Focusing on improving health education and access among vulnerable populations with lower levels of education and income is imperative for policymakers to mitigate health disparities. In addition, regional differences in disease prevalence are noteworthy. The north and south regions exhibit the highest rates of carotid artery stenosis, and this result is potentially linked to prevalent risk factors, such as diabetes and stroke, in these areas. This discrepancy can also arise from variations in healthcare quality across regions. For example, areas equipped with more advanced imaging tools and techniques may achieve earlier and more frequent diagnoses. Future research should explore the effects of diet, physical activity, and climate differences across regions to further analyze the reasons behind these disparities in prevalence.
However, several limitations must be acknowledged. First, this study focused on individuals who underwent carotid artery ultrasound examinations. This scenario may lead to a higher risk of detecting carotid artery stenosis and plaque compared with the general population. In addition, the assessment of carotid artery stenosis and plaque through ultrasound may be less reliable than magnetic resonance angiography or other forms of vascular imaging. Second, the sample size curtailed our capacity to provide in-depth provincial-level analyses. Nevertheless, our stratification of sampling sites into seven geographic categories facilitated a robust exploration of regional disparities. Third, this work is a cross-sectional study, and therefore, we cannot draw causal inferences that typically require longitudinal investigations. We can only establish associations between certain risk factors and the presence of carotid artery stenosis and plaque. Lastly, this study did not comprehensively incorporate potential confounding variables, such as dietary practices and medication adherence. Such oversight may result in an incomplete representation of the multifaceted interrelations between the identified risk factors and carotid artery conditions.
In summary, our research offers significant epidemiological data regarding the prevalence of carotid artery stenosis and plaque in China. For adults aged 40 years and above, the standardized prevalence rates for carotid artery stenosis and plaque were 3.9% and 36.3% respectively. Promoting targeted interventions for these at-risk populations, bolstered by customized health education programs, is imperative for China’s healthcare policymakers. In addition, increasing public awareness about the link between modifiable risk factors and these vascular anomalies is crucial. We believe that such strategies will effectively reduce the prevalence of carotid artery stenosis and plaque in China.

References

[1]
Katan M, Luft A. Global burden of stroke. Semin Neurol 2018; 38(2): 208–211
CrossRef Google scholar
[2]
GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021; 20(10): 795–820
CrossRef Google scholar
[3]
GBD 2017 DALYs, HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392(10159): 1859–1922
CrossRef Google scholar
[4]
Gao Y, Jiang B, Sun H, Ru X, Sun D, Wang L, Wang L, Jiang Y, Feigin VL, Wang Y, Wang W. The burden of stroke in China: results from a nationwide population-based epidemiological survey. PLoS One 2018; 13(12): e0208398
CrossRef Google scholar
[5]
Liu L, Wang D, Wong KSL, Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke 2011; 42(12): 3651–3654
CrossRef Google scholar
[6]
Tu WJ, Hua Y, Yan F, Bian H, Yang Y, Lou M, Kang D, He L, Chu L, Zeng J, Wu J, Chen H, Han J, Ma L, Cao L, Wang L. Prevalence of stroke in China, 2013–2019: a population-based study. Lancet Reg Health West Pac 2022; 28: 100550
CrossRef Google scholar
[7]
Paraskevas KI, Nicolaides AN, Kakkos SK. Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) study: what have we learned from it. Ann Transl Med 2020; 8(19): 1271
CrossRef Google scholar
[8]
Messas E, Goudot G, Halliday A, Sitruk J, Mirault T, Khider L, Saldmann F, Mazzolai L, Aboyans V. Management of carotid stenosis for primary and secondary prevention of stroke: state-of-the-art 2020: a critical review. Eur Heart J Suppl 2020; 22(Suppl M): M35–M42
CrossRef Google scholar
[9]
Xie Y, Yu M, Qing T, Luo H, Shao M, Wei W, Yi X. Variants in genes related to inflammation and endothelial function can increase the risk for carotid atherosclerosis in southwestern China. Front Neurol 2023; 14: 1174425
CrossRef Google scholar
[10]
Tang X, Zhang L, Li Y, Zhou Y, Cai X, Yao Y, Fang Q. Relationship between triglyceride–glucose index and carotid plaques in a high-stroke-risk population in southeast China: a population-based cross-sectional survey. Front Endocrin 2022; 13: 1023867
CrossRef Google scholar
[11]
Lin Y, Li Y, Li Z, Zhang Z, Liu J, Sun J, Tu J, Wang J, Zhang W, Li J, Ning X. Sex-related differences in the incidence and development of carotid plaques in a low-income Chinese population—a prospective cohort study. Int J Womens Health 2022; 14: 787–795
CrossRef Google scholar
[12]
Wang A, Tian X, Zuo Y, Wu J, Tang H, Wang Y, Zhao X. Association of remnant cholesterol with intra- and extra-cranial atherosclerosis in Chinese community population. Atheroscler Plus 2021; 46: 20–26
CrossRef Google scholar
[13]
Zhang Z, Fang X, Hua Y, Liu B, Ji X, Tang Z, Wang C, Guan S, Wu X, Liu H, Gu X. Combined effect of hyperhomocysteinemia and hypertension on the presence of early carotid artery atherosclerosis. J Stroke Cerebrovasc Dis 2016; 25(5): 1254–1262
CrossRef Google scholar
[14]
Yuan C, Lai CWK, Chan LWC, Chow M, Law HKW, Ying M. Cumulative effects of hypertension, dyslipidemia, and chronic kidney disease on carotid atherosclerosis in Chinese patients with type 2 diabetes mellitus. J Diabetes Res 2014; 2014: 179686
CrossRef Google scholar
[15]
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370(9596): 1453–1457
CrossRef Google scholar
[16]
Chao BH, Yan F, Hua Y, Liu JM, Yang Y, Ji XM, Peng B, Zhao GG, Wang YJ, Kang DZ, Wang YL, Zeng JS, Chu L, Li TX, Xu YM, Liu M, He L, Xu Y, Wu J, Lou M, Yue W, Cao L, Tu WJ, Wang LD. Stroke prevention and control system in China: CSPPC-Stroke Program. Int J Stroke 2021; 16(3): 265–272
CrossRef Google scholar
[17]
Ferguson GG, Eliasziw M, Barr HWK, Clagett GP, Barnes RW, Wallace MC, Taylor DW, Haynes RB, Finan JW, Hachinski VC, Barnett HJM. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke 1999; 30(9): 1751–1758
CrossRef Google scholar
[18]
Song P, Fang Z, Wang H, Cai Y, Rahimi K, Zhu Y, Fowkes FGR, Fowkes FJI, Rudan I. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health 2020; 8(5): e721–e729
CrossRef Google scholar
[19]
Fu J, Deng Y, Ma Y, Man S, Yang X, Yu C, Lv J, Wang B, Li L. National and provincial-level prevalence and risk factors of carotid atherosclerosis in Chinese adults. JAMA Netw Open 2024; 7(1): e2351225
CrossRef Google scholar
[20]
Dossabhoy S, Arya S. Epidemiology of atherosclerotic carotid artery disease. Semin Vasc Surg 2021; 34(1): 3–9
CrossRef Google scholar
[21]
de Weerd M, Greving JP, Hedblad B, Lorenz MW, Mathiesen EB, O’Leary DH, Rosvall M, Sitzer M, Buskens E, Bots ML. Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis. Stroke 2010; 41(6): 1294–1297
CrossRef Google scholar
[22]
Mathiesen EB, Joakimsen O, Bonaa KH. Prevalence of and risk factors associated with carotid artery stenosis: the Tromso Study. Cerebrovasc Dis 2001; 12(1): 44–51
CrossRef Google scholar
[23]
Clarke R, Du H, Kurmi O, Parish S, Yang M, Arnold M, Guo Y, Bian Z, Wang L, Chen Y, Meijer R, Sansome S, McDonnell J, Collins R, Li L, Chen Z. Burden of carotid artery atherosclerosis in Chinese adults: implications for future risk of cardiovascular diseases. Eur J Prev Cardiol 2017; 24(6): 647–656
CrossRef Google scholar
[24]
Zhao W, Wu Y, Shi M, Bai L, Tu J, Guo Z, Jiang R, Zhang J, Ning X, Wang J. Sex differences in prevalence of and risk factors for carotid plaque among adults: a population-based cross-sectional study in rural China. Sci Rep 2016; 6(1): 38618
CrossRef Google scholar
[25]
van Dam-Nolen DHK, van Egmond NCM, Dilba K, Nies K, van der Kolk AG, Liem MI, Kooi ME, Hendrikse J, Nederkoorn PJ, Koudstaal PJ, van der Lugt A, Bos D. Sex differences in plaque composition and morphology among symptomatic patients with mild-to-moderate carotid artery stenosis. Stroke 2022; 53(2): 370–378
CrossRef Google scholar
[26]
Sturlaugsdottir R, Aspelund T, Bjornsdottir G, Sigurdsson S, Thorsson B, Eiriksdottir G, Gudnason V. Prevalence and determinants of carotid plaque in the cross-sectional REFINE-Reykjavik study. BMJ Open 2016; 6(11): e012457
CrossRef Google scholar
[27]
Chou CL, Wu YJ, Hung CL, Liu CC, Wang SD, Wu TW, Wang LY, Yeh HI. Segment-specific prevalence of carotid artery plaque and stenosis in middle-aged adults and elders in Taiwan: a community-based study. J Formos Med Assoc 2019; 118(1): 64–71
CrossRef Google scholar
[28]
Kuo F, Gardener H, Dong C, Cabral D, Della-Morte D, Blanton SH, Elkind MSV, Sacco RL, Rundek T. Traditional cardiovascular risk factors explain the minority of the variability in carotid plaque. Stroke 2012; 43(7): 1755–1760
CrossRef Google scholar
[29]
Fabris F, Zanocchi M, Bo M, Fonte G, Poli L, Bergoglio I, Ferrario E, Pernigotti L. Carotid plaque, aging, and risk factors. A study of 457 subjects. Stroke 1994; 25(6): 1133–1140
CrossRef Google scholar
[30]
Lu SX, Wu TW, Chou CL, Cheng CF, Wang LY. Combined effects of hypertension, hyperlipidemia, and diabetes mellitus on the presence and severity of carotid atherosclerosis in community-dwelling elders: a community-based study. J Chin Med Assoc 2023; 86(2): 220–226
[31]
Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Primary Care 2013; 40(1): 195–211
CrossRef Google scholar
[32]
Ahmed ST, Li R, Richardson P, Ghosh S, Steele L, White DL, Djotsa AN, Sims K, Gifford E, Hauser ER, Virani SS, Morgan R, Delclos G, Helmer DA. Association of atherosclerotic cardiovascular disease, hypertension, diabetes, and hyperlipidemia with Gulf war illness among Gulf War veterans. J Am Heart Assoc 2023; 12(19): e029575
CrossRef Google scholar
[33]
Laguzzi F, Baldassarre D, Veglia F, Strawbridge RJ, Humphries SE, Rauramaa R, Smit AJ, Giral P, Silveira A, Tremoli E, Hamsten A, de Faire U, Frumento P, Leander K. Alcohol consumption in relation to carotid subclinical atherosclerosis and its progression: results from a European longitudinal multicentre study. Eur J Nutr 2021; 60(1): 123–134
CrossRef Google scholar
[34]
Britton A, Hardy R, Kuh D, Deanfield J, Charakida M, Bell S. Twenty-year trajectories of alcohol consumption during midlife and atherosclerotic thickening in early old age: findings from two British population cohort studies. BMC medicine 2016; 14(1): 111
CrossRef Google scholar
[35]
Oreopoulos A, Kalantar-Zadeh K, Sharma AM, Fonarow GC. The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med 2009; 25(4): 643–659
CrossRef Google scholar
[36]
Haberka M, Skilton M, Biedroń M, Szóstak-Janiak K, Partyka M, Matla M, Gąsior Z. Obesity, visceral adiposity and carotid atherosclerosis. J Diabetes Complications 2019; 33(4): 302–306
CrossRef Google scholar
[37]
Pan X, Chen X, Ren L, Li Z, Chen S. Correlation of obesity and overweight with cervical vascular function among healthy populations. Diabetes Metab Syndr Obes 2022; 15: 2927–2938
CrossRef Google scholar
[38]
Shen P, Zhou Y, Song A, Wan Y, Fan Z, Xu R. The association of metabolic health obesity with incidence of carotid artery plaque in Chinese adults. Nutr Metab Cardiovasc Dis 2021; 31(8): 2376–2381
CrossRef Google scholar
[39]
Hunt KJ, Duggirala R, Göring HHH, Williams JT, Almasy L, Blangero J, O’Leary DH, Stern MP. Genetic basis of variation in carotid artery plaque in the San Antonio Family Heart Study. Stroke 2002; 33(12): 2775–2780
CrossRef Google scholar
[40]
Bi Y, Qin Y, Su J, Cui L, Du WC, Miao WG, Li XB, Zhou JY. Prevalence and influencing factors of carotid plaque in population at high-risk for cardiovascular disease in Jiangsu province. Chinese Journal of Epidemiology (Zhonghua Liuxingbingxue Zazhi) 2019; 40(11): 1432–1438
[41]
Zhang K, Lin Q, Zhang T, Guo D, Cao L. Contemporary prevalence and risk factors of carotid artery stenosis in asymptomatic low-income Chinese individuals: a population-based study. Postgrad Med 2020; 132(7): 650–656
CrossRef Google scholar

Acknowledgements

We extend our heartfelt gratitude to all the patients, hospitals, and especially the medical professionals who were pivotal in clinical data collection and follow-up. This research was funded by the Chinese Academy of Medical Sciences Initiative for Innovative Medicine (No. 2022-I2M-1-019) and the National Social Science Fund of China (Nos. 22&ZD141 and 22AZD089). The funding bodies were not involved in any aspect of the study, from its conception and design to the collection, handling, analysis, or interpretation of data, nor in the drafting, reviewing, or approving of the manuscript.

Electronic Supplementary Material

Supplementary material is available in the online version of this article at https://doi.org/10.1007/s11684-024-1088-0 and accessible to authorized users.

Compliance with ethics guidelines

Conflicts of interest Qingjia Zeng, Chongyang Zhang, Xinyao Liu, Shengmin Yang, Muyuan Ma, Jia Tang, Tianlu Yin, Shanshan Zhao, Wenjun Tu, and Hongpu Hu declare no competing interests.
This study was approved by the appropriate Institutional and/or National Research Ethics Committee (the Ethics Committee of Capital Medical University Xuanwu Hospital), and the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all the patients for being included in the study.

RIGHTS & PERMISSIONS

2024 Higher Education Press
AI Summary AI Mindmap
PDF(1276 KB)

Supplementary files

FMD-24030-OF-TWJ_suppl_1 (121 KB)

439

Accesses

0

Citations

7

Altmetric

Detail

Sections
Recommended

/